The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Multiplex PCR Assays Market By 2030 Starting From Its 2026 Size?
The multiplex pcr assays market size has seen rapid growth in recent years. This market is expected to expand from $1.7 billion in 2025 to $1.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.4%. Historically, this expansion has been propelled by factors such as the increasing burden of infectious diseases, the rising adoption of molecular diagnostics, the limitations inherent in singleplex pcr testing, the growing demand for rapid diagnostic results, and the continued expansion of diagnostic laboratory infrastructure.
The multiplex pcr assays market is projected to experience substantial expansion over the upcoming years. It is forecasted to reach $3.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.2%. This growth during the forecast period is propelled by factors such as an increased emphasis on early disease identification, a surge in the need for all-encompassing diagnostic methods, the broadening scope of personalized medicine approaches, augmented investments in molecular diagnostics, and the wider integration of multiplex assays into standard testing procedures. Key trends defining this period encompass the growing integration of multiplex testing for infectious diseases, a heightened requirement for high-throughput diagnostic assays, the increasing application of syndromic testing panels, the broader utilization of multiplex pcr within clinical diagnostics, and a growing inclination towards cost-effective multi-target assays.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18681&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Multiplex PCR Assays Market?
The growth of the multiplex PCR assay market is anticipated to be propelled by the increasing demand for diagnostic testing. This type of testing involves procedures and analyses used to identify the presence or absence of a disease or condition in a patient. The rising need for diagnostic testing is primarily driven by the escalating incidence of chronic diseases like cancer and diabetes, which demand early and accurate diagnosis for effective management. Additionally, the increasing focus on preventive healthcare encourages regular screening to detect potential issues at an early stage. Multiplex PCR assays contribute significantly by allowing for the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample, thereby enhancing the efficiency and comprehensiveness of diagnostic processes. As an illustration, in July 2024, the National Health Service (NHS), a U.K.-based hospital and healthcare provider, stated that diagnostic activity exceeded pre-pandemic levels in 2023, noting a 21% increase in tests performed in May 2024 compared to 2023, with 2.4 million diagnostic tests carried out in May 2024. Ultimately, this growing demand for diagnostic testing will drive the expansion of the multiplex PCR assay market.
Which Segment Categories Define The Multiplex PCR Assays Market?
The multiplex pcr assays market covered in this report is segmented –
1) By Assay Type: Planar Assay, Bead Based Assay
2) By Product And Services: Consumables, Instruments, Software And Services
3) By Application: Disease Diagnosis, Research And Development, Other Applications
4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users
Subsegments:
1) By Planar Assay: Microarray-Based Assays, Dna Chip-Based Assays
2) By Bead Based Assay: Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays
What Major Market Trends Are Driving Changes In The Multiplex PCR Assays Market?
Leading companies in the multiplex PCR assays market are focusing on incorporating automation, such as next-generation quantitative PCR (qPCR) systems, to enable precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. These advanced qPCR systems facilitate high-throughput, accurate, and simultaneous detection of multiple targets, thereby enhancing diagnostic accuracy and efficiency. For example, in November 2023, Roche Diagnostics Corporation, a Switzerland-based diagnostic system solutions manufacturer, introduced the LightCycler PRO System. This particular next-generation qPCR platform provides high-throughput, precise, and simultaneous detection of multiple targets. It is characterized by improved temperature uniformity, sophisticated software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays, which collectively boost diagnostic accuracy and efficiency. This system perfectly illustrates the integration of automation within the Multiplex PCR Assays market, further advancing clinical diagnostics and public health.
Who Are The Top Companies Competing In The Multiplex PCR Assays Market?
Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc, Agena Bioscience, Fluidigm Corporation
Read the full multiplex pcr assays market report here:
https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report
Which Regions Are Projected To Dominate The Multiplex PCR Assays Market In The Coming Years?
North America was the largest region in the multiplex PCR assays market in 2025. The regions covered in the multiplex pcr assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Multiplex PCR Assays Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18681&type=smp
Browse Through More Reports Similar to the Global Multiplex PCR Assays Market 2026, By The Business Research Company
Multiplex Assays Market 2026
https://www.thebusinessresearchcompany.com/report/multiplex-assays-market
Polymerase Chain Reaction Pcr Technologies Market Report 2026
Multiplex Biomarker Imaging Market Report 2026
https://www.thebusinessresearchcompany.com/report/multiplex-biomarker-imaging-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model